Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Study Comparing Inotuzumab Ozogamicin in Combination With Rituximab Versus Defined Investigator's Choice in Follicular Non-Hodgkin's Lymphoma (NHL)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
Pharmaceutical / Industry
3129K4-3301
NCT00562965
2.
Study Evaluating CMC-544 Administered in Combination With Rituximab in Subjects With Non-Hodgkin's Lymphoma (NHL)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Active
18 and over
Pharmaceutical / Industry
3129K3-101
NCT00299494
3.
Study Evaluating the Safety and Tolerability of Combination Therapy Inotuzumab Ozogamicin (CMC-544) and Rituximab
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
20 to 74
Pharmaceutical / Industry
3129K3-1104
NCT00724971
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute